Management Team PDF Print E-mail
Name Position Background

Rudolf Fahrig
Prof. Dr.rer.nat.habil

CEO
Founder of RESprotect GmbH, Inventor of RP101

Geneticist, responsible for business and science. Conception and design of in vivo-screening systems and clinical studies.

Klaus Kutz
Prof. Dr. med.

CMO
Clinical Studies

Physician, long-time experience as Head of Clinical Pharmacology in two internationally operating pharmaceutical companies.

Jörg-Christian Heinrich
Dr.rer.nat.

CSO
Cell and Molecular Biology

Biologist, preclinical development of the drugs of the second generation. Elucidation of the mode of  action of RP101 and 2nd generation substances.

Torsten Fahrig
Dr.-Ing.

COO/CFO
Operation and Finances

Computer Scientist, responsible for finances, marketing and organisation.

Andreas Koch
Dr.-Ing.

Director
Chemistry and Pharmacy
Chemist, long-time experience in chemical syntheses. Preparation of drug master files, FDA and EMEA approvals.